Literature DB >> 19499974

Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters.

Hai-bo Wang1, Xiang-ping Liu, Jun Liang, Kun Yang, Ai-hua Sui, Yan-jun Liu.   

Abstract

BACKGROUND: Ras homologous (Rho) family GTPases play a pivotal role in the regulation of numerous cellular functions associated with malignant transformation and metastasis. To evaluate the role of these GTPases in colorectal cancer, the mRNA expression levels in matched sets of tumor and non-tumor tissues from surgical specimens were analyzed. The relationship between the mRNA levels in tumor tissues to the clinicopathological features was also assessed.
METHODS: A total of 68 patients with colorectal carcinoma were recruited and the levels of RhoA and RhoC mRNA transcripts in cancer, paratumoral and normal tissues were characterized by quantitative real-time polymerase chain reaction (QRT-PCR). Their correlation to clinical histopathological parameters was analyzed.
RESULTS: The levels of RhoA and RhoC mRNA transcripts in carcinoma tissues were significantly higher than those in the matched paratumor and normal tissues from the same patient (p<0.05). The expression levels of both genes were significantly correlated with metastasis of cancer cells to lymph nodes and liver (p<0.05). The levels of RhoA expression were significantly correlated with the histopathological degree of cancer, while the expression of RhoC was correlated with the extent of local invasion to intestine.
CONCLUSIONS: This is the first study with QRT-PCR to examine the expressions of RhoA and RhoC genes in colorectal carcinoma of Chinese patients. The significantly up-regulated RhoA and RhoC expressions suggest that they may contribute to the initiation, development, invasion and metastasis of colorectal carcinoma in Chinese patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19499974     DOI: 10.1515/CCLM.2009.186

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  12 in total

1.  Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells.

Authors:  Changhwan Yoon; Soo-Jeong Cho; Bülent Arman Aksoy; Do Joong Park; Nikolaus Schultz; Sandra W Ryeom; Sam S Yoon
Journal:  Clin Cancer Res       Date:  2015-10-19       Impact factor: 12.531

2.  Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling.

Authors:  Paolo P Provenzano; Patricia J Keely
Journal:  J Cell Sci       Date:  2011-04-15       Impact factor: 5.285

3.  Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549.

Authors:  Fang Zhu; Zhe Zhang; Gang Wu; Zhenyu Li; Ruiguang Zhang; Jinghua Ren; Li Nong
Journal:  Med Oncol       Date:  2010-03-19       Impact factor: 3.064

4.  Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo.

Authors:  Haibo Wang; Gang Zhao; Xiangping Liu; Aihua Sui; Kun Yang; Ruyong Yao; Zongbao Wang; Qiang Shi
Journal:  J Exp Clin Cancer Res       Date:  2010-09-09

5.  CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling.

Authors:  Amr A Al-haidari; Ingvar Syk; Karin Jirström; Henrik Thorlacius
Journal:  Int J Colorectal Dis       Date:  2013-05-07       Impact factor: 2.571

6.  De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach.

Authors:  Seda Ballikaya; Jennifer Lee; Uwe Warnken; Martina Schnölzer; Johannes Gebert; Jürgen Kopitz
Journal:  Mol Cell Proteomics       Date:  2014-09-15       Impact factor: 5.911

7.  Integration of mechanical and ECM microenvironment signals in the determination of cancer stem cell states.

Authors:  Tiina A Jokela; Mark A LaBarge
Journal:  Curr Stem Cell Rep       Date:  2020-11-23

8.  Gasdermin-B promotes invasion and metastasis in breast cancer cells.

Authors:  Marta Hergueta-Redondo; David Sarrió; Ángela Molina-Crespo; Diego Megias; Alba Mota; Alejandro Rojo-Sebastian; Pablo García-Sanz; Saleta Morales; Sandra Abril; Amparo Cano; Héctor Peinado; Gema Moreno-Bueno
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

Review 9.  Rho GTPases modulate malignant transformation of tumor cells.

Authors:  Jose L Orgaz; Cecilia Herraiz; Victoria Sanz-Moreno
Journal:  Small GTPases       Date:  2014-05-08

10.  Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value.

Authors:  Bo Zhang; Jiawei Yao; Xiaoyu Lian; Binfeng Liu; Yanbiao Wang; Hongbo Wang; Jialin Wang; Mengjun Zhang; Yaoye Zhao; Yongjie Zhu; Runze Liu; Yanzheng Gao
Journal:  Mol Clin Oncol       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.